Evaluation of the presence of 2-LTR HIV-1 unintegrated DNA as a simple molecular predictor of disease progression

Journal of Medical Virology

Volumn 52, Issue 1, 1997, Pages 20-25

  Zazzi, M ^a,b   Romano, L ^a   Catucci, M ^a   Venturi, G ^a   De Milito, A ^a   Almi, P ^b   Gonnelli, A ^b   Rubino, M ^b   Occhini, U ^c   Valensin, P E ^a,b  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY HOSPITAL OF SIENA   (Italy)

^c USL 9   (Italy)

Author keywords

disease progression; human immunodeficiency virus type 1; polymerase chain reaction; unintegrated DNA; zidovudine

Indexed keywords

ZIDOVUDINE;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC VALUE; DISEASE COURSE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ITALY; LONG TERMINAL REPEAT; MAJOR CLINICAL STUDY; PREDICTION; PROGNOSIS;

CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; DNA, CIRCULAR; DNA, VIRAL; HIV INFECTIONS; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; LEUKOCYTES, MONONUCLEAR; LONGITUDINAL STUDIES; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; RISK FACTORS; VIRUS INTEGRATION; ZIDOVUDINE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0030982057     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199705)52:1<20::AID-JMV4>3.0.CO;2-T     Document Type: Article

References (28)

1. Aukrust P, Liabakk NB, Mluller F, Lien E, Espevik T (1994): Serum levels of tumor necrosis factor-alpha (TNF-alpha) and soluble TNF receptors in human immunodeficiency virus type 1 infection - Correlation to clinical, immunologic, and virologic parameters. Journal of Infectious Diseases 169:420-424.
2. Bagnarelli P, Menzo S, Valenza A, Manzin A, Giacca M, Ancarani F, Scalise G, Varaldo PE, Clementi M (1992): Molecular profile in symptomless patients and in patients with AIDS. Journal of Virology 66:7328-7335.
3. Bilello JA, Stellrecht K, Drusano GL (1996): Soluble tumor necrosis factor-alpha receptor type II (sTNF-alpha RII) correlates with human immunodeficiency virus (HIV) RNA copy number in HIV-infected patients. Journal of Infectious Diseases 173:464-467.
4. Bush CE, Donovan RM, Smereck SM, Strang D, Markowitz N, Saravolatz LD (1993): Quantitation of unintegrated HIV-1 DNA in asymptomatic patients in the presence or absence of antiretroviral therapy. AIDS Research and Human Retroviruses 9:183-187.
5. Centers for Disease Control and Prevention (1992): 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morbidity and Mortality Weekly Report 41:1-18.
6. Chevret S, Kirstetter M, Mariotti M, Lefrere F, Frottier J, Lefrere J-J (1994): Provirus copy number to predict disease progression in asymptomatic human immunodeficiency virus type 1 infection. Journal of Infectious Diseases 169:882-885.
7. Dickover RE, Donovan RM, Goldstein E, Cohen SH, Bolton V, Huth RG, Liu G, Carlson JR (1992): Decreases in unintegrated HIV DNA are associated with antiretroviral therapy in AIDS patients. Journal of Acquired Immune Deficiency Syndromes 5:31-36.
8. Donovan RM, Bush CE, Smereck SM, Baxa DM, Markovitz NP, Saravolatz LD (1994): Rapid decrease in unintegrated human immunodeficiency virus DNA after the initiation of nucleoside therapy. Journal of Infectious Diseases 170:202-205.
9. Furtado MR, Kingsley LA, Wolinsky SM (1995): Changes in the viral mRNA expression pattern correlate with a rapid rate of CD4+ T-cell number decline in human immunodeficiency virus type 1-infected individuals. Journal of Virology 69:2092-2100.
10. Gupta P, Kingsley L, Armstrong J, Ding M, Cottrill M, Rinaldo C (1993): Enhanced expression of human immunodeficiency virus type 1 correlates with development of AIDS. Virology 196:586-595.
11. Iacobelli S, Ullrich A, Tinari N, Ortona L, Tamburrini E, D'Egidio M, Ghinelli F, Sighinolfi L, Piazza M, Chirianni A (1995): The 90K tumor-associated antigen and clinical progression in human immunodeficiency virus infection. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology 10:450-456.
12. Jurriaans S, de Ronde A, Dekker J, Goudsmit J, Cornelissen M (1992): Analysis of human immunodeficiency virus type 1 LTR-LTR junctions in peripheral blood mononuciear cells of infected individuals. Journal of General Virology 73:1537-1541.
13. Jurriaans S, de Ronde A, Dekker J, Cornelissen M, Goudsmit J (1995): Increased number of single-LTR HIV-I DNA junctions correlates with HIV-1 antigen expression and CD4+ cell decline in vivo. Journal of Medical Virology 45:91-98.
14. Katzenstein TL, Pedersen C, Nielsen C, Lundgren JD, Jacobsen PH, Gerstoff J (1996): Longitudinal serum HIV RNA quantification: Correlation to viral phenotype at seroconversion and clinical outcome. AIDS 10:167-173.
15. Larder BA, Kellam P, Kemp SD (1991): Zidovudine resistance predicted by direct detection of mutations in DNA from HIV-infected lymphocytes. AIDS 5:137-144.
16. Lee T-H, Sheppard HW, Reis M, Dondero D, Osmond D, Busch MP (1994): Circulating HIV-1-infected cell burden from seroconversion to AIDS: Importance of postseroconversion viral load on disease course. Journal of Acquired Immune Deficiency Syndromes 7:381-388.
17. Mellors JW, Kingsley LA, Rinaldo CR, Todd JA, Hoo BS, Kokka RP, Gupta P (1995): Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Annals of Internal Medicine 122: 575-579.
18. Merigan TC, Hirsch RL, Fisher AC, Meyerson LA, Goldstein G, Winters MA (1996): The prognostic significance of serum viral load, codon 215 reverse transcriptase mutation and CD4+ T cells on progression of HIV disease in a double-blind study of thymopentin. AIDS 10:159-165.
19. Nicholson WJ, Shepherd AJ, Aw DW-J (1996): Detection of unintegrated HIV type 1 DNA in cell culture and clinical peripheral blood mononuclear cell samples: Correlation to disease stage. AIDS Research and Human Retroviruses 12:315-323.
20. Pang S, Koyanagi Y, Miles S, Wiley C, Vinters HV, Chen ISY (1990): High levels of unintegrated HIV-1 DNA in brain tissue of AIDS dementia patients. Nature 343:85-89.
21. Pauza CD, Trivedi P, McKechnie TS, Richman DD, Graziano FM (1994): 2-LTR circular viral DNA as a marker for human immunodeficiency virus type 1 infection in vivo. Virology 205:470-478.
22. Piatak M, Saag MS, Yang LC, Clark SJ, Kappes JC, Luk K-C, Hahn BH, Shaw GM, Lifson JD (1993): High levels of HIV-1 in plasma during all stages of infection determined by competitive PCR. Science 259:1749-1754.
23. Pouchier RAM, Brouwer M, Broersen SM, Schuitemaker H (1995): Simple determination of human immunodeficiency virus type 1 syncytium-inducing V3 genotype by PCR. Journal of Clinical Microbiology 33:906-911.
24. Saiki RK, Gelfand DH, Stoffel S, Scharf SJ, Higuchi R, Horn CT, Mullis KB, Erlich HA (1988): Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239: 487-491.
25. Saksela K, Stevens C, Rubinstein P, Baltimore D (1994): Human immunodeficiency virus type 1 mRNA expression in peripheral blood cells predicts disease progression independently of the number of CD4+ lymphocytes. Proceedings of the National Academy of Science, USA 81:1104-1108.
26. Tsoukas CM, Bernard NF (1994): Markers predicting progression of human immunodeficiency virus-related disease. Clinical Microbiology Reviews 7:14-28.
27. Zazzi M, Romano L, Brasini A, Valensin PE (1993a): Simultaneous amplification of multiple HIV-1 DNA sequences from clinical specimens by using nested-primer polymerase chain reaction. AIDS Research and Human Retroviruses 9:315-320.
28. Zazzi M, Romano L, Peruzzi F, Toneatto S, De Milito A, Botta G, Valensin PE (1993b): Optimal conditions for detection of human immunodeficiency virus type 1 DNA by polymerase chain reaction with nested primers. Molecular and Cellular Probes 7:433-437.